Dwayne Johnson on Health, Fatherhood, and Taking a Closer Look

Hyman walked through the logical chain: Dwayne’s story pinpointed the start of symptoms after antibiotics; a stool test confirmed absent Akkermansia; the therapeutic shake was formulated not just as a generic probiotic but as a targeted intervention to regrow that specific protective layer. He contrasted this with the symptomatic guesswork Dwayne had experienced with other doctors, where he was given pills that didn’t address the root cause. The protocol is part of functional medicine’s core approach: identify the missing commensal and feed it. This requires a detailed history, appropriate stool analysis, and a custom blend rather than an off-the-shelf solution.

Hyman pointed out that 93% of Americans have some degree of insulin resistance, which drives the formation of dangerous cholesterol particles even when total LDL appears normal. He argued that by using Apo B and advanced lipoprotein testing, clinicians can avoid both under- and over-treatment. In Dwayne’s case, his Apo B and insulin resistance score were perfect, and his inflammation was low, despite a genetically low HDL. This constellation gave high confidence that no plaque was forming, making the idea of plaque on the scan contradictory and prompting further imaging. Hyman’s protocol is to let the comprehensive bloodwork guide the next step rather than reacting to a single alarming scan.

Hyman used the AI scan as the decisive test after Dwayne’s conventional scan flagged possible plaque in the circumflex artery. He emphasized that traditional MRI and CT interpretations are operator-dependent and often err on the side of caution, leading to overtreatment. The AI analysis provided a definitive read that the finding was normal anatomy. Hyman advocated for this technology as part of a movement toward precision diagnostics that minimize unnecessary interventions. He noted that costs are dropping, making annual scanning feasible for many, and that combining it with blood biomarkers gives a 360-degree view.

Hyman framed dementia as a condition people fear like cancer, but one that is now actionable. He argued that screening with these tools allows people to take proactive lifestyle measures—diet, exercise, cognitive training—that can alter the trajectory. Dwayne’s case was instructive: he feared dementia due to family history, but found he carries the APOE2/3 protective genotype and had a clean p-tau217, giving him a strong sense of relief and a clear incentive to maintain his current healthy habits. Hyman’s message is that testing removes the unknown and replaces it with a plan.

Hyman highlighted that standard medical practice rarely checks nutritional markers, so people can feel ‘fine’ but operate below optimal. He positioned this approach as foundational to functional medicine: assess the baseline of cellular nutrition before looking for pathology. In Dwayne’s case, the nutrient gaps were discovered incidentally during his broader workup, and Hyman framed it as low-hanging fruit—easy, inexpensive interventions that significantly improve overall function. This also serves as a cautionary tale that external appearance of health can mask internal shortages.

Hyman shared personal stories: his father died of lung cancer and his sister of bile duct cancer, both caught late. He argued that such screening would have saved them. He acknowledged that previously full-body MRI was a luxury for the wealthy, but now cost and time have fallen dramatically (from an hour to 22 minutes). He tied it to Dwayne’s grandfather, who refused to see a doctor and died at 45 from metastatic cancer. The vision is that routine, affordable scanning can make dying from cancer a thing of the past, akin to how mammograms reduced breast cancer mortality. He stressed that this technology is becoming democratized through services like Function Health.

Mark Hyman explained that Dwayne’s chronic digestive problems began after two rounds of antibiotics, which wiped out Akkermansia, a bacterium that coats the intestinal lining and prevents food proteins and bacteria from leaking into the bloodstream and causing systemic inflammation. Standard doctors did not connect the antibiotic history to the gut symptoms and instead offered symptomatic treatments. Hyman’s approach was to first take a thorough history, identifying that moment as the trigger, then use a stool test to confirm the missing Akkermansia. The repair protocol involved a custom shake (probiotics plus plant polyphenols from pomegranate, green tea, and cranberry) that specifically supports Akkermansia regrowth. This illustrates the functional medicine tenet of treating root causes, not symptoms. The implication is that many post-antibiotic gut syndromes are reversible if practitioners look for—and know how to restore—specific keystone bacteria.

Hyman stated that the majority of Americans are metabolically unhealthy due to excess starch and sugar intake, leading to insulin resistance and a pattern of dangerous cholesterol particles. Apo B captures the total number of atherogenic particles, and when paired with advanced lipoprotein fractionation, reveals the size and number of particles—information that directly reflects metabolic health. Dwayne asked why this test is not part of standard workups. Hyman replied that doctors get an order form established when they begin practice and rarely modify it; changing practice workflows and assimilating new science is difficult, even when doctors want to adapt. He noted that the speed of scientific advancement outstrips the average clinician’s ability to update, leaving patients with outdated risk assessments. This creates a scenario where people may be told their cholesterol is fine while harboring high-risk particle numbers, or conversely, may be put on medication unnecessarily.

Dwayne had a conventional scan that suggested plaque buildup in the circumflex artery. His cardiologist immediately recommended a multi-month medication course. Hyman urged holding off and arranged an AI-enhanced scan. The AI readout determined the finding was merely an anatomical variant, not plaque. Hyman contrasted this with the general practice of jumping to medication without corroborating advanced imaging. He argued that AI interpretation dramatically improves resolution and reduces false positives, and because the cost has dropped, it can be done annually. This example illustrates the power of combining AI imaging with advanced blood biomarkers (Apo B, inflammation, insulin) to get a complete picture. The message is that technology exists to avoid both unnecessary drug exposure and missed disease.

Hyman explained that dementia is terrifying particularly for those with a family history. He offered Dwayne a multi-modal screen: APOE genotyping (to see genetic susceptibility), the p-tau217 blood test (to look for active Alzheimer’s protein markers), and brain imaging. He emphasized that Alzheimer’s is preventable—intensive lifestyle therapy can slow or even reverse early disease. He mentioned that knowing one’s status allows proactive changes, and that a clean p-tau217 combined with favorable genetics gives strong reassurance. This approach epitomizes the ‘test, don’t guess’ philosophy and the idea that even dreaded diseases can be intercepted early.

Hyman explained that Dwayne ate the same clean, macronutrient-complete meals daily (complex carbs, protein, greens), yet functional lab panels revealed multiple gaps. These deficiencies, he noted, are common because modern food systems and individual variation mean that even a ‘good’ diet may not deliver optimal levels. Because doctors don’t typically check nutritional status unless frank disease is present, people can go years with suboptimal function—fatigue, immune issues, subtle cognitive dips—without knowing why. Correcting these with simple supplementation can yield noticeable improvements. This illustrates his broader argument that standard medical checkups miss the foundational elements of health.